Synchron’s Switch technology is implanted through blood vessels in the brain and designed to allow patients with limited or no mobility to operate computers with their minds. So far, the technology has been used by three patients in the U.S. and four in Australia.
In December, the company received $75 million in series C financing led by Arch Venture Partners.
Bezos Expeditions and Gates Frontier participated in the round that brought the company’s total capital raised to $145 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
